nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ABCB1—Rifampicin—leprosy	0.122	0.478	CbGbCtD
Mefloquine—CYP3A4—Rifampicin—leprosy	0.0731	0.286	CbGbCtD
Mefloquine—Glucose-6-phosphate dehydrogenase deficiency—Dapsone—leprosy	0.0712	0.206	CcSEcCtD
Mefloquine—HBA1—hindlimb—leprosy	0.0621	0.155	CbGeAlD
Mefloquine—CYP3A4—Dapsone—leprosy	0.0603	0.236	CbGbCtD
Mefloquine—HBA2—hindlimb—leprosy	0.057	0.143	CbGeAlD
Mefloquine—HBA1—appendage—leprosy	0.0532	0.133	CbGeAlD
Mefloquine—HBA2—appendage—leprosy	0.0489	0.122	CbGeAlD
Mefloquine—HBA2—blood vessel—leprosy	0.0272	0.0681	CbGeAlD
Mefloquine—Peripheral sensory neuropathy—Thalidomide—leprosy	0.016	0.0464	CcSEcCtD
Mefloquine—HBA1—eye—leprosy	0.0158	0.0395	CbGeAlD
Mefloquine—ADORA1—nerve—leprosy	0.0156	0.039	CbGeAlD
Mefloquine—HBA2—eye—leprosy	0.0145	0.0362	CbGeAlD
Mefloquine—HBA1—skin of body—leprosy	0.0137	0.0343	CbGeAlD
Mefloquine—HBA2—skin of body—leprosy	0.0126	0.0315	CbGeAlD
Mefloquine—HBA1—testis—leprosy	0.00865	0.0216	CbGeAlD
Mefloquine—HBA1—nervous system—leprosy	0.00849	0.0212	CbGeAlD
Mefloquine—Foetor hepaticus—Thalidomide—leprosy	0.00805	0.0233	CcSEcCtD
Mefloquine—HBA2—testis—leprosy	0.00794	0.0199	CbGeAlD
Mefloquine—HBA2—nervous system—leprosy	0.00779	0.0195	CbGeAlD
Mefloquine—Liver disorder—Thalidomide—leprosy	0.0067	0.0194	CcSEcCtD
Mefloquine—Psychotic disorder—Dapsone—leprosy	0.00633	0.0183	CcSEcCtD
Mefloquine—Neuritis—Thalidomide—leprosy	0.00612	0.0177	CcSEcCtD
Mefloquine—Muscular weakness—Dapsone—leprosy	0.00571	0.0166	CcSEcCtD
Mefloquine—Drug interaction—Thalidomide—leprosy	0.00492	0.0143	CcSEcCtD
Mefloquine—Neuropathy peripheral—Dapsone—leprosy	0.00489	0.0142	CcSEcCtD
Mefloquine—Leukocytosis—Thalidomide—leprosy	0.00486	0.0141	CcSEcCtD
Mefloquine—Hearing impaired—Thalidomide—leprosy	0.0048	0.0139	CcSEcCtD
Mefloquine—Atrioventricular block—Thalidomide—leprosy	0.00471	0.0137	CcSEcCtD
Mefloquine—Coordination abnormal—Thalidomide—leprosy	0.00465	0.0135	CcSEcCtD
Mefloquine—Hepatocellular injury—Thalidomide—leprosy	0.00457	0.0132	CcSEcCtD
Mefloquine—ADORA1—tendon—leprosy	0.00431	0.0108	CbGeAlD
Mefloquine—Neuropathy—Thalidomide—leprosy	0.00429	0.0124	CcSEcCtD
Mefloquine—Aplastic anaemia—Thalidomide—leprosy	0.00429	0.0124	CcSEcCtD
Mefloquine—ACHE—tendon—leprosy	0.00428	0.0107	CbGeAlD
Mefloquine—Tinnitus—Dapsone—leprosy	0.00418	0.0121	CcSEcCtD
Mefloquine—ADORA2A—testis—leprosy	0.00413	0.0103	CbGeAlD
Mefloquine—ADORA2A—nervous system—leprosy	0.00406	0.0101	CbGeAlD
Mefloquine—Erythema—Dapsone—leprosy	0.0039	0.0113	CcSEcCtD
Mefloquine—Deafness—Thalidomide—leprosy	0.00371	0.0107	CcSEcCtD
Mefloquine—Vision blurred—Dapsone—leprosy	0.00368	0.0107	CcSEcCtD
Mefloquine—ADORA1—testis—leprosy	0.00357	0.00893	CbGeAlD
Mefloquine—ACHE—testis—leprosy	0.00355	0.00887	CbGeAlD
Mefloquine—Vertigo—Dapsone—leprosy	0.0035	0.0102	CcSEcCtD
Mefloquine—ADORA1—nervous system—leprosy	0.0035	0.00876	CbGeAlD
Mefloquine—Visual disturbance—Thalidomide—leprosy	0.0035	0.0101	CcSEcCtD
Mefloquine—Dermatitis bullous—Thalidomide—leprosy	0.00347	0.0101	CcSEcCtD
Mefloquine—Affect lability—Thalidomide—leprosy	0.00326	0.00946	CcSEcCtD
Mefloquine—Psychotic disorder—Thalidomide—leprosy	0.00324	0.00939	CcSEcCtD
Mefloquine—Mood swings—Thalidomide—leprosy	0.00314	0.00911	CcSEcCtD
Mefloquine—Ataxia—Thalidomide—leprosy	0.00312	0.00904	CcSEcCtD
Mefloquine—Tachycardia—Dapsone—leprosy	0.00311	0.00901	CcSEcCtD
Mefloquine—Cramp muscle—Thalidomide—leprosy	0.00299	0.00866	CcSEcCtD
Mefloquine—Muscular weakness—Thalidomide—leprosy	0.00292	0.00848	CcSEcCtD
Mefloquine—Insomnia—Dapsone—leprosy	0.00288	0.00835	CcSEcCtD
Mefloquine—ABCB1—blood vessel—leprosy	0.00285	0.00712	CbGeAlD
Mefloquine—BCHE—skin of body—leprosy	0.00277	0.00692	CbGeAlD
Mefloquine—Gastrointestinal pain—Dapsone—leprosy	0.0026	0.00755	CcSEcCtD
Mefloquine—Pneumonia—Thalidomide—leprosy	0.00257	0.00745	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00253	0.00735	CcSEcCtD
Mefloquine—Abdominal pain—Dapsone—leprosy	0.00252	0.0073	CcSEcCtD
Mefloquine—Body temperature increased—Dapsone—leprosy	0.00252	0.0073	CcSEcCtD
Mefloquine—Renal failure—Thalidomide—leprosy	0.00251	0.00728	CcSEcCtD
Mefloquine—Neuropathy peripheral—Thalidomide—leprosy	0.0025	0.00726	CcSEcCtD
Mefloquine—Sweating—Thalidomide—leprosy	0.00245	0.0071	CcSEcCtD
Mefloquine—CYP19A1—testis—leprosy	0.00242	0.00605	CbGeAlD
Mefloquine—Agranulocytosis—Thalidomide—leprosy	0.00238	0.00692	CcSEcCtD
Mefloquine—CYP19A1—nervous system—leprosy	0.00238	0.00594	CbGeAlD
Mefloquine—Bradycardia—Thalidomide—leprosy	0.00234	0.00677	CcSEcCtD
Mefloquine—Visual impairment—Thalidomide—leprosy	0.00221	0.00641	CcSEcCtD
Mefloquine—Erythema multiforme—Thalidomide—leprosy	0.00217	0.00629	CcSEcCtD
Mefloquine—Eye disorder—Thalidomide—leprosy	0.00214	0.00622	CcSEcCtD
Mefloquine—Tinnitus—Thalidomide—leprosy	0.00214	0.0062	CcSEcCtD
Mefloquine—Cardiac disorder—Thalidomide—leprosy	0.00213	0.00617	CcSEcCtD
Mefloquine—Angiopathy—Thalidomide—leprosy	0.00208	0.00604	CcSEcCtD
Mefloquine—Mediastinal disorder—Thalidomide—leprosy	0.00207	0.006	CcSEcCtD
Mefloquine—Chills—Thalidomide—leprosy	0.00206	0.00597	CcSEcCtD
Mefloquine—Alopecia—Thalidomide—leprosy	0.00203	0.00588	CcSEcCtD
Mefloquine—Vomiting—Dapsone—leprosy	0.00202	0.00587	CcSEcCtD
Mefloquine—Mental disorder—Thalidomide—leprosy	0.00201	0.00583	CcSEcCtD
Mefloquine—Malnutrition—Thalidomide—leprosy	0.002	0.00579	CcSEcCtD
Mefloquine—Headache—Dapsone—leprosy	0.00199	0.00578	CcSEcCtD
Mefloquine—Muscle spasms—Thalidomide—leprosy	0.00192	0.00557	CcSEcCtD
Mefloquine—Nausea—Dapsone—leprosy	0.00189	0.00548	CcSEcCtD
Mefloquine—Vision blurred—Thalidomide—leprosy	0.00188	0.00546	CcSEcCtD
Mefloquine—Tremor—Thalidomide—leprosy	0.00187	0.00543	CcSEcCtD
Mefloquine—Ill-defined disorder—Thalidomide—leprosy	0.00185	0.00537	CcSEcCtD
Mefloquine—Agitation—Thalidomide—leprosy	0.00184	0.00532	CcSEcCtD
Mefloquine—Malaise—Thalidomide—leprosy	0.0018	0.00522	CcSEcCtD
Mefloquine—Vertigo—Thalidomide—leprosy	0.00179	0.0052	CcSEcCtD
Mefloquine—Syncope—Thalidomide—leprosy	0.00179	0.00519	CcSEcCtD
Mefloquine—Leukopenia—Thalidomide—leprosy	0.00179	0.00518	CcSEcCtD
Mefloquine—Palpitations—Thalidomide—leprosy	0.00176	0.00512	CcSEcCtD
Mefloquine—Loss of consciousness—Thalidomide—leprosy	0.00176	0.00509	CcSEcCtD
Mefloquine—BCHE—testis—leprosy	0.00174	0.00436	CbGeAlD
Mefloquine—Convulsion—Thalidomide—leprosy	0.00173	0.00502	CcSEcCtD
Mefloquine—Hypertension—Thalidomide—leprosy	0.00172	0.005	CcSEcCtD
Mefloquine—BCHE—nervous system—leprosy	0.00171	0.00428	CbGeAlD
Mefloquine—Chest pain—Thalidomide—leprosy	0.0017	0.00493	CcSEcCtD
Mefloquine—Myalgia—Thalidomide—leprosy	0.0017	0.00493	CcSEcCtD
Mefloquine—Arthralgia—Thalidomide—leprosy	0.0017	0.00493	CcSEcCtD
Mefloquine—Anxiety—Thalidomide—leprosy	0.00169	0.00491	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00169	0.0049	CcSEcCtD
Mefloquine—Discomfort—Thalidomide—leprosy	0.00168	0.00487	CcSEcCtD
Mefloquine—Confusional state—Thalidomide—leprosy	0.00164	0.00477	CcSEcCtD
Mefloquine—Oedema—Thalidomide—leprosy	0.00163	0.00473	CcSEcCtD
Mefloquine—Shock—Thalidomide—leprosy	0.0016	0.00465	CcSEcCtD
Mefloquine—Nervous system disorder—Thalidomide—leprosy	0.0016	0.00463	CcSEcCtD
Mefloquine—Thrombocytopenia—Thalidomide—leprosy	0.0016	0.00463	CcSEcCtD
Mefloquine—Tachycardia—Thalidomide—leprosy	0.00159	0.00461	CcSEcCtD
Mefloquine—Skin disorder—Thalidomide—leprosy	0.00158	0.00459	CcSEcCtD
Mefloquine—Hyperhidrosis—Thalidomide—leprosy	0.00158	0.00457	CcSEcCtD
Mefloquine—Hypotension—Thalidomide—leprosy	0.00152	0.00442	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00148	0.00431	CcSEcCtD
Mefloquine—Insomnia—Thalidomide—leprosy	0.00147	0.00427	CcSEcCtD
Mefloquine—Paraesthesia—Thalidomide—leprosy	0.00146	0.00424	CcSEcCtD
Mefloquine—Dyspnoea—Thalidomide—leprosy	0.00145	0.00421	CcSEcCtD
Mefloquine—Somnolence—Thalidomide—leprosy	0.00145	0.0042	CcSEcCtD
Mefloquine—Dyspepsia—Thalidomide—leprosy	0.00143	0.00416	CcSEcCtD
Mefloquine—Decreased appetite—Thalidomide—leprosy	0.00142	0.00411	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Thalidomide—leprosy	0.00141	0.00408	CcSEcCtD
Mefloquine—Fatigue—Thalidomide—leprosy	0.00141	0.00407	CcSEcCtD
Mefloquine—Feeling abnormal—Thalidomide—leprosy	0.00134	0.00389	CcSEcCtD
Mefloquine—Gastrointestinal pain—Thalidomide—leprosy	0.00133	0.00386	CcSEcCtD
Mefloquine—Urticaria—Thalidomide—leprosy	0.00129	0.00375	CcSEcCtD
Mefloquine—Abdominal pain—Thalidomide—leprosy	0.00129	0.00374	CcSEcCtD
Mefloquine—Body temperature increased—Thalidomide—leprosy	0.00129	0.00374	CcSEcCtD
Mefloquine—Hypersensitivity—Thalidomide—leprosy	0.0012	0.00348	CcSEcCtD
Mefloquine—Asthenia—Thalidomide—leprosy	0.00117	0.00339	CcSEcCtD
Mefloquine—CYP2D6—testis—leprosy	0.00115	0.00289	CbGeAlD
Mefloquine—Pruritus—Thalidomide—leprosy	0.00115	0.00334	CcSEcCtD
Mefloquine—CYP3A4—nervous system—leprosy	0.00115	0.00288	CbGeAlD
Mefloquine—CYP2D6—nervous system—leprosy	0.00113	0.00284	CbGeAlD
Mefloquine—Diarrhoea—Thalidomide—leprosy	0.00112	0.00323	CcSEcCtD
Mefloquine—Dizziness—Thalidomide—leprosy	0.00108	0.00313	CcSEcCtD
Mefloquine—Vomiting—Thalidomide—leprosy	0.00104	0.003	CcSEcCtD
Mefloquine—Rash—Thalidomide—leprosy	0.00103	0.00298	CcSEcCtD
Mefloquine—Dermatitis—Thalidomide—leprosy	0.00103	0.00298	CcSEcCtD
Mefloquine—Headache—Thalidomide—leprosy	0.00102	0.00296	CcSEcCtD
Mefloquine—Nausea—Thalidomide—leprosy	0.000968	0.00281	CcSEcCtD
Mefloquine—ABCB1—testis—leprosy	0.000831	0.00208	CbGeAlD
Mefloquine—ABCB1—nervous system—leprosy	0.000815	0.00204	CbGeAlD
